News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) Reports 2013 Second Quarter Financial Results


8/7/2013 6:49:11 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAVAL, Quebec , Aug. 7, 2013 /CNW/ -

  • Total Revenue $1.1 billion ; an increase of 41% over the prior year, excluding one-time items in 2012 second quarter


  • Product Sales $1.06 billion ; an increase of 43% over the prior year


  • Hey, check out all the research scientist jobs. Post your resume today!

    Read at Yahoo Finance


    comments powered by Disqus
       

    ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES